iShares MSCI Germany (DAX) vs 22nd Century Group Inc — how do they compare? iShares MSCI Germany (DAX) trades at $40.96 (market cap $1.42B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: iShares MSCI Germany (DAX) is far larger — about 2284.2× 22nd Century Group Inc's market cap, and iShares MSCI Germany (DAX) is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Germany (DAX) for 54 Days and 22nd Century Group Inc for 32 Days on average.
| EWG | XXII | |
|---|---|---|
Market Cap | $1.42B | $621.67K |
Volume | 1,110,573 | 45,625 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $44.59 | $483.00 |
52-Week Low | $38.08 | $0.80 |
Typical Hold Time | 54 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
EWG trades at $40.96 with minimal daily movement (+0.12%). Technical indicators show a bearish trend with strong selling pressure across moving averages and oscillators, though RSI levels suggest potential oversold conditions. The stock faces resistance at $41 with support at $40. Recent European market news highlights mixed sentiment with resilient equities but concerns about ECB rate hikes and energy-driven inflation pressures.
The outlook remains cautious due to bearish technicals and macroeconomic headwinds from potential ECB tightening. Investment opportunity exists if oversold RSI levels trigger a rebound, but risks include further rate hikes and energy price volatility. Stock performance hinges on European economic stability and inflation control.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →